Selected research
Industry Research
Latanoprost API Industry Research Report 2026
Market perspective
The global Latanoprost API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Latanoprost API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Latanoprost API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Latanoprost API include Sanofi, Guangzhou Tosun Pharmaceutical, Ausun Pharm, Summit Pharmaceuticals, NEWCHEM, Gentec Pharmaceutical Group, Fleming Laboratories, Euroapi and Dr Pradeep Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Latanoprost API market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Latanoprost API Market by Company
Sanofi
Guangzhou Tosun Pharmaceutical
Ausun Pharm
Summit Pharmaceuticals
NEWCHEM
Gentec Pharmaceutical Group
Fleming Laboratories
Euroapi
Dr Pradeep Reddy’s Laboratories
DongWha Pharm
DEAFARMA
Chemo
Century Pharmaceuticals
Cayman Pharma
Berr Chemical
Aspen Biopharma
Latanoprost API Segment by Type
Liquid
Powder
Latanoprost API Segment by Application
Glaucoma
High Eye Pressure
Others
Latanoprost API Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Latanoprost API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Latanoprost API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Latanoprost API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Latanoprost API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid
- Powder
Applications
- Glaucoma
- High Eye Pressure
- Others
Companies covered
- Sanofi
- Guangzhou Tosun Pharmaceutical
- Ausun Pharm
- Summit Pharmaceuticals
- NEWCHEM
- Gentec Pharmaceutical Group
- Fleming Laboratories
- Euroapi
- Dr Pradeep Reddy’s Laboratories
- DongWha Pharm
- DEAFARMA
- Chemo
- Century Pharmaceuticals
- Cayman Pharma
- Berr Chemical
- Aspen Biopharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Latanoprost API Market Size (2021-2032)
- 2.2.2 Global Latanoprost API Sales (2021-2032)
- 2.2.3 Global Latanoprost API Market Average Price (2021-2032)
- 2.3 Latanoprost API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid
- 2.3.3 Powder
- 2.4 Latanoprost API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Glaucoma
- 2.4.3 High Eye Pressure
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Latanoprost API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Latanoprost API Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Latanoprost API Revenue of Manufacturers (2021-2026)
- 3.4 Global Latanoprost API Average Price by Manufacturers (2021-2026)
- 3.5 Global Latanoprost API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Latanoprost API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Latanoprost API, Product Type & Application
- 3.8 Global Manufacturers of Latanoprost API, Established Date
- 3.9 Global Latanoprost API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Latanoprost API Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 Guangzhou Tosun Pharmaceutical
- 4.2.1 Guangzhou Tosun Pharmaceutical Company Information
- 4.2.2 Guangzhou Tosun Pharmaceutical Business Overview
- 4.2.3 Guangzhou Tosun Pharmaceutical Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Guangzhou Tosun Pharmaceutical Latanoprost API Product Portfolio
- 4.2.5 Guangzhou Tosun Pharmaceutical Recent Developments
- 4.3 Ausun Pharm
- 4.3.1 Ausun Pharm Company Information
- 4.3.2 Ausun Pharm Business Overview
- 4.3.3 Ausun Pharm Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ausun Pharm Latanoprost API Product Portfolio
- 4.3.5 Ausun Pharm Recent Developments
- 4.4 Summit Pharmaceuticals
- 4.4.1 Summit Pharmaceuticals Company Information
- 4.4.2 Summit Pharmaceuticals Business Overview
- 4.4.3 Summit Pharmaceuticals Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Summit Pharmaceuticals Latanoprost API Product Portfolio
- 4.4.5 Summit Pharmaceuticals Recent Developments
- 4.5 NEWCHEM
- 4.5.1 NEWCHEM Company Information
- 4.5.2 NEWCHEM Business Overview
- 4.5.3 NEWCHEM Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 NEWCHEM Latanoprost API Product Portfolio
- 4.5.5 NEWCHEM Recent Developments
- 4.6 Gentec Pharmaceutical Group
- 4.6.1 Gentec Pharmaceutical Group Company Information
- 4.6.2 Gentec Pharmaceutical Group Business Overview
- 4.6.3 Gentec Pharmaceutical Group Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Gentec Pharmaceutical Group Latanoprost API Product Portfolio
- 4.6.5 Gentec Pharmaceutical Group Recent Developments
- 4.7 Fleming Laboratories
- 4.7.1 Fleming Laboratories Company Information
- 4.7.2 Fleming Laboratories Business Overview
- 4.7.3 Fleming Laboratories Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fleming Laboratories Latanoprost API Product Portfolio
- 4.7.5 Fleming Laboratories Recent Developments
- 4.8 Euroapi
- 4.8.1 Euroapi Company Information
- 4.8.2 Euroapi Business Overview
- 4.8.3 Euroapi Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Euroapi Latanoprost API Product Portfolio
- 4.8.5 Euroapi Recent Developments
- 4.9 Dr Pradeep Reddy’s Laboratories
- 4.9.1 Dr Pradeep Reddy’s Laboratories Company Information
- 4.9.2 Dr Pradeep Reddy’s Laboratories Business Overview
- 4.9.3 Dr Pradeep Reddy’s Laboratories Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Dr Pradeep Reddy’s Laboratories Latanoprost API Product Portfolio
- 4.9.5 Dr Pradeep Reddy’s Laboratories Recent Developments
- 4.10 DongWha Pharm
- 4.10.1 DongWha Pharm Company Information
- 4.10.2 DongWha Pharm Business Overview
- 4.10.3 DongWha Pharm Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 DongWha Pharm Latanoprost API Product Portfolio
- 4.10.5 DongWha Pharm Recent Developments
- 4.11 DEAFARMA
- 4.11.1 DEAFARMA Company Information
- 4.11.2 DEAFARMA Business Overview
- 4.11.3 DEAFARMA Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 DEAFARMA Latanoprost API Product Portfolio
- 4.11.5 DEAFARMA Recent Developments
- 4.12 Chemo
- 4.12.1 Chemo Company Information
- 4.12.2 Chemo Business Overview
- 4.12.3 Chemo Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chemo Latanoprost API Product Portfolio
- 4.12.5 Chemo Recent Developments
- 4.13 Century Pharmaceuticals
- 4.13.1 Century Pharmaceuticals Company Information
- 4.13.2 Century Pharmaceuticals Business Overview
- 4.13.3 Century Pharmaceuticals Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Century Pharmaceuticals Latanoprost API Product Portfolio
- 4.13.5 Century Pharmaceuticals Recent Developments
- 4.14 Cayman Pharma
- 4.14.1 Cayman Pharma Company Information
- 4.14.2 Cayman Pharma Business Overview
- 4.14.3 Cayman Pharma Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Cayman Pharma Latanoprost API Product Portfolio
- 4.14.5 Cayman Pharma Recent Developments
- 4.15 Berr Chemical
- 4.15.1 Berr Chemical Company Information
- 4.15.2 Berr Chemical Business Overview
- 4.15.3 Berr Chemical Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Berr Chemical Latanoprost API Product Portfolio
- 4.15.5 Berr Chemical Recent Developments
- 4.16 Aspen Biopharma
- 4.16.1 Aspen Biopharma Company Information
- 4.16.2 Aspen Biopharma Business Overview
- 4.16.3 Aspen Biopharma Latanoprost API Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Aspen Biopharma Latanoprost API Product Portfolio
- 4.16.5 Aspen Biopharma Recent Developments
5 Global Latanoprost API Market Scenario by Region
- 5.1 Global Latanoprost API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Latanoprost API Sales by Region: 2021-2032
- 5.2.1 Global Latanoprost API Sales by Region: 2021-2026
- 5.2.2 Global Latanoprost API Sales by Region: 2027-2032
- 5.3 Global Latanoprost API Revenue by Region: 2021-2032
- 5.3.1 Global Latanoprost API Revenue by Region: 2021-2026
- 5.3.2 Global Latanoprost API Revenue by Region: 2027-2032
- 5.4 North America Latanoprost API Market Facts & Figures by Country
- 5.4.1 North America Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Latanoprost API Sales by Country (2021-2032)
- 5.4.3 North America Latanoprost API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Latanoprost API Market Facts & Figures by Country
- 5.5.1 Europe Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Latanoprost API Sales by Country (2021-2032)
- 5.5.3 Europe Latanoprost API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Latanoprost API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Latanoprost API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Latanoprost API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Latanoprost API Market Facts & Figures by Country
- 5.7.1 South America Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Latanoprost API Sales by Country (2021-2032)
- 5.7.3 South America Latanoprost API Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Latanoprost API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Latanoprost API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Latanoprost API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Latanoprost API Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Latanoprost API Sales by Type (2021-2032)
- 6.1.1 Global Latanoprost API Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Latanoprost API Sales Market Share by Type (2021-2032)
- 6.2 Global Latanoprost API Revenue by Type (2021-2032)
- 6.2.1 Global Latanoprost API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Latanoprost API Revenue Market Share by Type (2021-2032)
- 6.3 Global Latanoprost API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Latanoprost API Sales by Application (2021-2032)
- 7.1.1 Global Latanoprost API Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Latanoprost API Sales Market Share by Application (2021-2032)
- 7.2 Global Latanoprost API Revenue by Application (2021-2032)
- 7.2.1 Global Latanoprost API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Latanoprost API Revenue Market Share by Application (2021-2032)
- 7.3 Global Latanoprost API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Latanoprost API Value Chain Analysis
- 8.1.1 Latanoprost API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Latanoprost API Production Mode & Process
- 8.2 Latanoprost API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Latanoprost API Distributors
- 8.2.3 Latanoprost API Customers
9 Global Latanoprost API Analyzing Market Dynamics
- 9.1 Latanoprost API Industry Trends
- 9.2 Latanoprost API Industry Drivers
- 9.3 Latanoprost API Industry Opportunities and Challenges
- 9.4 Latanoprost API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst